Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.05
-0.15 (-2.88%)
At close: Sep 1, 2026, 4:00 PM EDT
5.07
+0.02 (0.40%)
Pre-market: Sep 2, 2026, 5:56 AM EDT

[Name] Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, [Name] stock has a consensus rating of "Strong Buy" and an average price target of $28.22. The average 1-year stock price forecast is 458.81% higher than the current stock price, while the lowest is $15 (+197.03%) and the highest is $50 (+890.10%).

Price Target: $28.22 (+458.81%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$15$28.22$25$50
Change+197.03%+458.81%+395.05%+890.10%

Analyst Ratings

The average analyst rating for [Name] stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy778887
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total991010109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Benchmark Co.
Benchmark Co.
Buy
Maintains
$13$15
BuyMaintains$13$15+197.03%Aug 20, 2026
Maxim Group
Maxim Group
Buy
Maintains
$30
BuyMaintains$30+494.06%Aug 18, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$22$20
BuyMaintains$22$20+296.04%Aug 13, 2026
Noble Financial
Noble Financial
Buy
Reiterates
$50
BuyReiterates$50+890.10%Aug 13, 2026
Guggenheim
Guggenheim
Buy
Maintains
$37$25
BuyMaintains$37$25+395.05%Aug 13, 2026

Financial Forecast

Revenue This Year
275.38K
Revenue Next Year
145.41M
from 275.38K
Increased by 52,701.90%
EPS This Year
-1.21
from -1.67
EPS Next Year
1.41
from -1.21
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-951.00K675.00K--275.38K
Gross Profit
-951.00K675.00K--261.61K
Gross Margin
-100.00%100.00%--95.00%
Operating Income
-8.98M-18.05M-20.77M-32.12M-29.52M-38.28M
Net Income
-10.02M-18.06M-30.54M-36.73M-26.56M-34.12M
EPS
-----1.67-1.21
Free Cash Flow
-4.60M-9.26M1.57M-12.17M-22.92M-32.60M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.7M
Avg275,380
Lown/a

Revenue Growth

Revenue Growth20272028
High
111,442.2%
Avg
52,701.9%
Low
12,306.5%

EPS Forecast

EPS202620272028
High-0.62
Avg-1.21
Low-1.44

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-